azacitidine has been researched along with Febrile Neutropenia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 6 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertani, G; Calado, RT; Daigle, SR; de Botton, S; Döhner, H; Gianolio, DA; Heuser, M; Hui, J; Montesinos, P; Pandya, SS; Recher, C; Schuh, AC; Vives, S; Wang, J; Yeh, SP; Zarzycka, E | 1 |
| Arora, S; Bachiashvili, K; Bathini, S; Bhatia, R; Di Stasi, A; Diamond, B; Godby, K; Gupta, U; Jamy, O; Oliver, JD; Rangaraju, S; Salzman, D; Vachhani, P; Worth, S; Zainaldin, C | 1 |
| Arnan, M; Baer, MR; Brevard, J; Cortes, JE; De Botton, S; Dinner, SN; Donnellan, W; Ferrell, PB; Forsyth, S; Guichard, SM; Henrick, P; Jonas, BA; Kelly, P; Lee, S; Marzac, C; Mohamed, H; Montesinos, P; Pigneux, A; Prebet, T; Récher, C; Schiller, GJ; Schwarer, AP; Seiter, KP; Sweeney, J; Wang, ES; Watts, JM; Wei, AH; Yang, J | 1 |
| Matsuda, K; Sugimoto, K; Yoshida, T | 1 |
| Adès, L; Angeli, E; Bally, C; Calleja, A; Chevallier, P; Cluzeau, T; Fenaux, P; Garnier, A; Guillaume, T; Jullien, M; Le Bourgeois, A; Le Gouill, S; Ngo Nloga, AM; Peterlin, P | 1 |
| Ajib, S; Bornhäuser, M; Bug, G; Crysandt, M; Dressler, S; Haas, R; Hausmann, A; Heidenreich, D; Hirschbühl, K; Hoepting, M; Jost, E; Kaivers, J; Klein, S; Kobbe, G; Koldehoff, M; Kordelas, L; Kriege, O; Müller, LP; Rautenberg, C; Schaffrath, J; Schmid, C; Schroeder, T; Schuler, E; Wagner-Drouet, EM; Wolff, D | 1 |
| Hanamoto, H; Ishikawa, J; Kawata, S; Maeda, Y; Matsuda, M; Matsumura, I; Morita, Y; Shibayama, H; Tsubaki, K; Urase, F; Yamaguchi, T | 1 |
| Ades, L; Banos, A; Beve, B; Chait, Y; Chaury, MP; Cheze, S; Cluzeau, T; Dartigeas, C; Delaunay, J; Dombret, H; Dreyfus, F; Fenaux, P; Gardin, C; Guerci, A; Ifrah, N; Isnard, F; Itzykson, R; Marfaing Koka, A; Marolleau, JP; Morel, P; Pautas, C; Plantier, I; Quesnel, B; Raffoux, E; Recher, C; Seegers, V; Stamatoullas, A; Taksin, AL; Thépot, S; Thomas, X; Vey, N | 1 |
| Choi, CW; Do, YR; Jang, JH; Jeong, SH; Joo, YD; Kim, HG; Kim, I; Kim, SJ; Kim, SR; Kim, YJ; Kim, YK; Lee, JH; Lee, WS; Mun, YC; Na, SM; Park, SK; Yi, HG | 1 |
| Aoki, K; Muta, T; Ogawa, R; Shimamoto, S; Tamura, Y; Yoshihiro, T | 1 |
1 review(s) available for azacitidine and Febrile Neutropenia
| Article | Year |
|---|---|
Efficacy and adverse events of azacitidine in the treatment of hemodialysis patients with high-risk myelodysplastic syndrome.
Topics: Aged; Azacitidine; Blood Transfusion; Febrile Neutropenia; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Renal Dialysis; Risk Factors | 2016 |
3 trial(s) available for azacitidine and Febrile Neutropenia
| Article | Year |
|---|---|
Ivosidenib and Azacitidine in
Topics: Antineoplastic Agents; Azacitidine; Febrile Neutropenia; Glycine; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Leukopenia; Pyridines; Recurrence | 2022 |
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Febrile Neutropenia; Female; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Thrombocytopenia | 2023 |
Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single-arm phase 2 trial.
Topics: Aged; Aged, 80 and over; Anemia, Refractory; Anemia, Sideroblastic; Antimetabolites, Antineoplastic; Azacitidine; Blood Component Transfusion; Drug Administration Schedule; Feasibility Studies; Febrile Neutropenia; Female; Humans; Japan; Male; Middle Aged; Prospective Studies; Thrombocytopenia; Treatment Outcome | 2018 |
6 other study(ies) available for azacitidine and Febrile Neutropenia
| Article | Year |
|---|---|
Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Decitabine; Febrile Neutropenia; Humans; Leukemia, Myeloid, Acute; Retrospective Studies; Sulfonamides; Tumor Lysis Syndrome | 2022 |
High susceptibility of febrile neutropenia in Japanese patients receiving venetoclax plus azacitidine therapy for acute myeloid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; East Asian People; Febrile Neutropenia; Humans; Leukemia, Myeloid, Acute | 2023 |
Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients.
Topics: Abnormal Karyotype; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow Diseases; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Febrile Neutropenia; Female; France; Hospitalization; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Multicenter Studies as Topic; Myelodysplastic Syndromes; Renal Insufficiency, Chronic; Retrospective Studies; Treatment Outcome | 2020 |
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Topics: Allografts; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Combined Modality Therapy; Decitabine; DNA Methylation; Drug Evaluation; Febrile Neutropenia; Germany; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Leukocyte Count; Myelodysplastic Syndromes; Recurrence; Retrospective Studies; Salvage Therapy; Sulfonamides; Thrombocytopenia; Transplantation Conditioning; Tumor Lysis Syndrome | 2021 |
Azacitidine in untreated acute myeloid leukemia: a report on 149 patients.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Cohort Studies; Compassionate Use Trials; Febrile Neutropenia; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Sepsis; Treatment Outcome | 2014 |
A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Febrile Neutropenia; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Remission Induction; Republic of Korea; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2015 |